Bioherent

Bioherent provides a diagnostic test that identifies specific drug allergies through advanced immunoassay technology. This test enables healthcare providers to make informed decisions, reducing the risk of adverse drug reactions in patients.

Traction 8/10

Alhaurín de la Torre, Spain · HQ

Founded 2021161K+ followers

Biotechnology
Healthcare Technology
Medical Devices

Updated 7 months ago

Funding

Raised to date

$3.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Jonas Leuermann

CEO

Product

Features

Bioherent provides a diagnostic test that identifies specific drug allergies through advanced immunoassay technology. This test enables healthcare providers to make informed decisions, reducing the risk of adverse drug reactions in patients.